The Shanghai Stock Exchange announced after market close on September 4th that, in accordance with the relevant provisions of the "Shanghai-Hong Kong Stock Connect Implementation Measures," IMPACT THERAP-B (07630) has been officially added to the list of eligible securities under the Stock Connect scheme. This adjustment is set to take effect on Monday, September 7th.
With this inclusion, mainland investors can now directly buy and sell shares of IMPACT THERAP-B through the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, marking the formal activation of southbound capital flow into the company's stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments